Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Oxford Science Enterprises Plc investment portfolio

Oxford Science Enterprises Plc has made numerous investments in companies such as Refeyn, Opsydia, and Nucleome Therapeutics within the AI sector.

university
Portfolio
79
Team
0

Portfolio (79)

CompanySectorCitySourceLast confirmed on
Aistetic Limited
Aistetic Limited offers an AI‑driven software platform that automatically generates complete, marketplace‑ready product listings—including titles, descriptions, pricing and structured data—for fashion retailers and resale platforms, enabling them to list and sell items within the circular fashion market.
Software & ITAbingdonConfirmed2026-01-17
Alethio Therapeutics Limited
Alethio Therapeutics Limited is a biotechnology company developing monoclonal antibody‑drug conjugate therapeutics for the treatment of myeloproliferative neoplasms and other blood‑cancer diseases. Its pipeline includes ADC programmes such as AT‑01 and AT‑02 that aim to provide disease‑modifying therapies for these conditions.
Healthcare & Life SciencesAbingdonConfirmed2025-07-12

Sign up to see the full portfolio

+77 more companies

Sign up

Shareholding changes (62)

Oxford Science Enterprises Plc's positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+60 more changes

Sign up

Articles (10)